查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
生物製劑外包市場：按產品類型、按應用、按國家、按地區-行業分析、市場規模、市場份額、2023-2030 年預測
市場調查報告書
商品編碼
1290847

生物製劑外包市場：按產品類型、按應用、按國家、按地區-行業分析、市場規模、市場份額、2023-2030 年預測

Biologics Outsourcing Market with COVID-19 Impact Analysis, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 379 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022年生物製劑外包市場規模將達到804.103億美元，2023年至2030年復合年增長率為18.7%

生物製品外包市場-市場動態

為了經濟地利用先進生物製劑的開發和製造能力，生物製藥公司的外包趨勢不斷增加，預計這將推動市場的增長。

生物製藥行業外包趨勢的日益增長使公司能夠以具有成本效益的方式獲得先進的生物製劑開發和製造能力。外包使公司能夠利用先進的設施、設備和專業知識，而無需進行大量資本投資。CRO（合同研究實驗室）和 CMO（合同製造組織）配備了經驗豐富的科學家和工程師，具備處理複雜生物製品工藝所需的技能。截至2023年，美國共有合同研究機構2823家，較2022年增長0.9%。根據美國行業統計，CRO行業的運營成本佔銷售額的比例為工資（29.1%）、採購（6.8%）、租金和水電費（3.4%）。通過利用我們外包合作夥伴的專業知識和基礎設施，公司可以優化運營、降低財務風險並加速生物製品商業化。

生物製劑外包市場 - 主要見解

  • 由於可持續增長意識的增強，預計生物製品外包行業將出現顯著增長
  • 從產品類型來看，抗體將是2022年的主要類型
  • 從應用來看，2022年治療藥物將成為主要類型。
  • 按地區劃分，北美將在 2022 年銷量領先。

生物製品外包市場細分分析：

全球生物製品外包市場根據特異性、類型、應用和區域進行細分。

根據產品類型，市場分為五類：抗體、基因工程、蛋白質、疫苗和其他。抗體主導市場。這些是常見的外包類型的生物製劑。抗體是免疫系統響應外來物質（例如病原體或異常細胞）的存在而產生的蛋白質。外包抗體開發和製造為生物製藥公司提供了多種優勢。

市場按應用分為三類：治療、診斷和研究。治療藥物在市場上佔據主導地位，並將在預測期內保持其主導地位。外包生物製劑用於治療，通常用於治療癌症、自身免疫性疾病和遺傳性疾病等複雜疾病。生物製劑外包市場是指與生物製劑和治療藥物的開發、製造和商業化相關的各種流程的外包。

生物製劑外包市場 - 地理洞察

從地理上看，該市場遍布北美、拉丁美洲、歐洲、亞太地區、中東和非洲。這些區域根據我們開展業務的國家/地區進一步細分。由於生物製藥公司研發支出增加以及生物類似藥的批准和推廣增加，預計生物製品外包市場將由北美主導。北美生物製藥公司投入大量資源進行研發活動。我們對研究和開發的關注促進了創新生物製劑和療法的開發。美國藥物研究與製造商協會預測，美國生物製藥行業在新藥開發方面處於世界領先地位，PhRMA成員公司繼續走在前列。2020年美國生物製藥研發投資總額預計為1220億美元。由於細胞系工程（基因編輯工具）和細胞系開發技術的技術進步，預計歐洲和亞太地區將推動生物製劑外包市場的顯著增長。

生物製劑外包市場 - 競爭格局：

公司在研發方面投入巨資，以提高細胞系開發技能、開發新產品並探索新穎的治療應用。生物製劑外包市場競爭激烈，多家公司爭奪市場份額。例如，Boehringer Ingelheim將在2023年斥資3.86億美元在德國開設一家研發工廠。Boehringer Ingelheim表示，生物製劑開發中心（BDC）將開發抗體和治療性蛋白質，並生產用於臨床試驗的材料。生物仿製藥的增長及其開發和製造的需求也增加了對生物製劑外包的需求。生物仿製藥開發商通常依賴外包合作夥伴來利用他們的專業知識和基礎設施。

近期動向

2022 年4 月，全球領先的生物製藥、細胞、遺傳和消費醫學合作夥伴能夠通過多種方式優化開發、商業化和提供更好的患者治療方法康泰倫特宣布收購了牛津附近目前正在建設的生物製劑開發和製造工廠，英國，來自英國疫苗、製造和創新中心有限公司（VMIC Ltd.）。

研究的主要特點

  • 這份生物製劑外包市場研究報告提供了以2022年為基準年的市場規模、複合年增長率（CAGR%）、估計和預測（2023-2030年）。
  • 該研究報告為客戶提供了有關生物製劑外包市場最新發展的見解。
  • 該研究報告闡明了不同細分市場/國家的潛在增長機會，並說明了生物製品外包市場有吸引力的投資主張矩陣。
  • 總體報告確定了新的投資機會、現有企業面臨的挑戰以及生物製劑外包市場可持續發展的增長動力。
  • 研究範圍詳細探討了COVID-19對生物製品外包市場規模、預測、複合年增長率和市場動態的影響。還涵蓋了對後COVID-19生物製品外包市場的深入見解。
  • 為了向本報告的用戶提供生物製品外包市場的全面了解，我們還對生物製品外包市場的競爭格局和主要創新者進行了分析。
  • 該研究涵蓋了基於市場規模、增長率和吸引力對所有行業領域進行基準測試的增長前景映射分析。
  • 提供主要市場進入者的詳細公司概況，以幫助您了解在生物製劑外包市場運營的公司的財務信息和戰略舉措。
  • 此外，報告還揭示了市場主要進入者不僅在全球層面而且在區域層面的重大收購和兼併、聯盟和合資企業、新產品推出、研發和區域擴張。
  • 全球生物製劑外包市場報告主要針對該行業的各個利益相關者，如供應商、投資者、新進入者、分銷商和財務分析師。

目錄

第一章 生物製劑外包市場概況

  • 調查範圍

第二章執行摘要

  • 市場細分
  • 競爭考慮

第三章 生物製劑外包市場主要趨勢

  • 生物製劑外包市場驅動因素
  • 生物製劑外包市場製約因素
  • 生物製品外包市場機遇
  • 生物製品外包市場的未來趨勢

第四章 生物製品外包行業概況

  • PEST分析
  • 波特五力分析
  • 繪製增長前景
  • 監管框架分析

第五章 生物製品外包市場：COVID-19 的影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後的影響分析

第六章 生物製劑外包市場格局

  • 2022 年生物製品外包市場份額分析
  • 主要製造商的細分數據
    • 已成立公司分析
    • 啟動分析

7. 生物製品外包市場——按產品類型

  • 概述
    • 按產品類型劃分的細分市場份額分析
    • 抗體
    • 重組
    • 蛋白質
    • 疫苗接種
    • 其他

8. 生物製劑外包市場——按應用

  • 概述
    • 按應用劃分的細分市場份額分析
    • 治療
    • 診斷
    • 研究

9.生物製劑外包市場——按地區

  • 介紹
  • 北美
    • 概述
    • 主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商
    • 德國
    • 意大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 其他
  • 亞太地區 (APAC)
    • 概述
    • 主要製造商
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳大利亞
    • 泰國
    • 印度尼西亞
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲
    • 概述
    • 主要製造商
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第十章主要供應商分析-生物製劑外包行業

  • 比賽儀表板
  • 公司簡介
    • Boehringer Ingelheim
    • Catalent
    • GenScript
    • Innovent Biologics
    • Syngene
    • Shanghai Medicilon
    • GL Biochem Corporation
    • GVK Biosciences Private
    • Horizon Discovery Group
    • Selexis
    • Lonza
    • Abzena
    • Adimab

第十一章 分析師的全面看法

Product Code: ANV1293

REPORT HIGHLIGHT

The Biologics Outsourcing Market size was valued at USD 80,410.3 million in 2022, expanding at a CAGR of 18.7% from 2023 to 2030.

Biologics are a more complex class of medicines to manufacture, package, store, and distribute than their chemical counterparts. Outsourcing of any aspect of the supply chain means pharmaceutical companies and their chosen vendors need to work in true partnership, navigating the complex process together to ensure speed to market. Developing and manufacturing biologic drugs in-house can be costly due to the need for specialized facilities, equipment, and personnel. Outsourcing allows companies to avoid or reduce these capital investments and instead pay for specific services or processes as needed, potentially resulting in cost savings.

Biologics Outsourcing Market- Market Dynamics

Increasing trend of outsourcing among biopharma companies to gain economical access to advanced biologics development and manufacturing capacities is expected to propel market growth

The increasing trend of outsourcing in the biopharmaceutical industry enables companies to gain access to advanced biologics development and manufacturing capacities in a cost-effective manner. Outsourcing allows companies to access advanced facilities, equipment, and expertise without the need for substantial capital investments. contract research organizations (CROs)and contract manufacturing organizations (CMOs) are equipped with experienced scientists and technicians who possess the necessary skills to handle complex biologics processes. There are 2,823 Contract Research Organizations businesses in the US as of 2023, an increase of 0.9% from 2022. The highest costs for business in The Contract Research Organizations industry in the US as a percentage of revenue are Wages (29.1%), Purchases (6.8%), and Rent & Utilities (3.4%, according to industry statistics of U.S. By leveraging the expertise and infrastructure of outsourcing partners, companies can optimize their operations, reduce financial risks, and accelerate the commercialization of their biologic products.

Biologics Outsourcing Market- Key Insights

  • As per the analysis shared by our research analyst, the global Biologics outsourcing market is estimated to grow annually at a CAGR of around XX% over the forecast period (2023-2030)
  • The Biologics outsourcing industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on product type segmentation, Antibody was the leading type in 2022
  • Based on Application segmentation, Therapeutics was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Biologics Outsourcing Market- Segmentation Analysis:

The Global Biologics Outsourcing Market is segmented on the basis of specificity, Type, Application, and Region.

The market is divided into five categories based on Product Type: Antibody, Recombinant, Protein, Vaccines, and Others. Antibody dominates the market. These are commonly outsourced types of biological products. Antibodies are proteins produced by the immune system in response to the presence of foreign substances, such as pathogens or abnormal cells. Outsourcing the development and manufacturing of antibodies can offer several advantages to biopharmaceutical companies.

The market is divided into three categories based on Application: Therapeutics, Diagnostics, and Research. Therapeutics dominate the market and are likely to maintain their dominance during the forecast period. Biologics Outsources are used for therapeutic purposes, often to treat complex diseases like cancer, autoimmune disorders, or genetic diseases. The biologics outsourcing market refers to the outsourcing of various processes related to the development, manufacturing, and commercialization of biologic drugs or therapeutics.

Biologics Outsourcing Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate Biologics Outsourcing Market, due to increasing R&D spend of biopharma companies and escalating approvals and uptake of biosimilar. Biopharmaceutical companies in North America have been allocating significant resources to research and development activities. This focus on R&D allows them to develop innovative biologic drugs and therapies. Pharmaceutical Research and Manufacturers of America predicted that the U.S. biopharmaceutical industry has been the world leader in the development of new medicines, and PhRMA member companies continue to be at the forefront. The entire U.S. biopharmaceutical invested an estimated USD122 billion in R&D in 2020. Europe and Asia Pacific are expected to propel significant growth in Biologics Outsourcing Market, due to the Technological advancements in cell line engineering (gene editing tools) & cell line development technologies.

Biologics Outsourcing Market- Competitive Landscape:

Companies invest heavily in research and development to enhance their cell line development technologies, develop new products, and explore novel therapeutic applications. These players offer a wide range of services, including contract research, contract manufacturing, clinical trial services, and other support services for biopharmaceutical companies The Biologics outsourcing market is highly competitive, with several companies vying for market share. For instance, in 2023, Boehringer Ingelheim opens a USD386m German R&D plant. The Biologics Development Center (BDC) will develop antibodies and therapeutic proteins and manufacture substances for clinical trials, says Boehringer Ingelheim. The growth of biosimilar and the need for their development and manufacturing are also contributing to the demand for biologics outsourcing. Biosimilar developers often rely on outsourcing partners to leverage their expertise and infrastructure.

Recent Developments:

In April 2022, Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize the development, launch, and supply of better patient treatments across multiple modalities, nowadays announced the acquisition from Vaccine Manufacturing and Innovation Centre UK Limited (VMIC Ltd.) of a biologics development and manufacturing facility currently under construction near Oxford, U.K.

Key features of the study:

  • This proposed research study on Biologics outsourcing market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Biologics outsourcing market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Biologics outsourcing market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Biologics outsourcing market
  • Impact of COVID-19 on Biologics outsourcing market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Biologics outsourcing market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Biologics outsourcing market, we have also included competitive landscape and key innovator analysis for the Biologics outsourcing market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Biologics outsourcing market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Biologics outsourcing market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOLOGICS OUTSOURCING MARKET KEY PLAYERS

  • Boehringer Ingelheim
  • Catalent
  • GenScript
  • Innovent Biologics
  • Syngene
  • Shanghai Medicilon
  • GL Biochem Corporation
  • GVK Biosciences Private
  • Horizon Discovery Group
  • Selexis
  • Lonza
  • Abzena
  • Adimab

GLOBAL BIOLOGICS OUTSOURCING MARKET, BY PRODUCT TYPE

  • Antibody
  • Recombinant
  • Protein
  • Vaccines
  • Others

GLOBAL BIOLOGICS OUTSOURCING MARKET, BY APPLICATION

  • Therapeutics
  • Diagnostics
  • Research

GLOBAL BIOLOGICS OUTSOURCING MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

TABLE OF CONTENT

1. Biologics Outsourcing Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Biologics Outsourcing Market Snippet by Product Type
    • 2.1.2. Biologics Outsourcing Market Snippet by Application
    • 2.1.3. Biologics Outsourcing Market Snippet by Country
    • 2.1.4. Biologics Outsourcing Market Snippet by Region
  • 2.2. Competitive Insights

3. Biologics Outsourcing Key Market Trends

  • 3.1. Biologics Outsourcing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Biologics Outsourcing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Biologics Outsourcing Market Opportunities
  • 3.4. Biologics Outsourcing Market Future Trends

4. Biologics Outsourcing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Biologics Outsourcing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Biologics Outsourcing Market Landscape

  • 6.1. Biologics Outsourcing Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Biologics Outsourcing Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Antibody
    • 7.1.3. Recombinant
    • 7.1.4. Protein
    • 7.1.5. Vaccines
    • 7.1.6. Others

8. Biologics Outsourcing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Therapeutics
    • 8.1.3. Diagnostics
    • 8.1.4. Research

9. Biologics Outsourcing Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Biologics Outsourcing Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Biologics Outsourcing Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Biologics Outsourcing Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Biologics Outsourcing Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Biologics Outsourcing Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Biologics Outsourcing Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Boehringer Ingelheim
    • 10.2.2. Catalent
    • 10.2.3. GenScript
    • 10.2.4. Innovent Biologics
    • 10.2.5. Syngene
    • 10.2.6. Shanghai Medicilon
    • 10.2.7. GL Biochem Corporation
    • 10.2.8. GVK Biosciences Private
    • 10.2.9. Horizon Discovery Group
    • 10.2.10. Selexis
    • 10.2.11. Lonza
    • 10.2.12. Abzena
    • 10.2.13. Adimab

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Biologics Outsourcing Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Biologics Outsourcing Market, by Product Type 2018-2030 (USD Million)
  • TABLE Biologics Outsourcing Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Biologics Outsourcing Market, by Application 2018-2030 (USD Million)
  • TABLE Biologics Outsourcing Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Biologics Outsourcing Market, by Region 2018-2030 (USD Million)
  • TABLE North America Biologics Outsourcing Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Biologics Outsourcing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Biologics Outsourcing Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Biologics Outsourcing Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Biologics Outsourcing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Biologics Outsourcing Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biologics Outsourcing Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biologics Outsourcing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biologics Outsourcing Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Biologics Outsourcing Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Biologics Outsourcing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Biologics Outsourcing Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biologics Outsourcing Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biologics Outsourcing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biologics Outsourcing Market, by Application, 2018-2030 (USD Million)